No 13 (2014)
News. Findings and events
DISEASES OF THE UPPER GASTROINTESTINAL TRACT
6-9 582
Abstract
Antacids, along with proton pump inhibitors, play an important role in the treatment of acid-base disorders. Almagel® medicines are the most common antacid preparations showing high efficiency. The administration results in a rapid relief of symptoms, earlier healing of lesions in the gastrointestinal mucosa and improvement in the quality of life of patients.
10-13 423
Abstract
The article is a literature review of the major etiopathogenetic mechanisms of the development and recent approaches to the treatment of gastroesophageal reflux disease in patients with metabolic syndrome. Recent data on the role of insulin resistance, impaired neurohumoral regulation of the upper gastrointestinal tract in patients with gastroesophageal reflux disease and metabolic syndrome is presented.
14-17 385
Abstract
The article presents the results of a study aimed to evaluate the efficacy and tolerability of eradication schemes with macrolides and bismuth in the treatment of patients with Helicobacter pylori related functional dyspepsia (postprandial distress syndrome).
18-21 553
Abstract
The past decades have recorded sustainably high incidence of non-alcoholic fatty liver disease (NAFLD) globally. The disease is more prevalent among people with obesity and diabetes mellitus (DM), dyslipidemia and metabolic syndrome (MS) [3, 4]. NAFLD is an independent nosological unit including a range of clinical and morphological changes of the liver parenchyma: steatosis (fatty degeneration) and non-alcoholic steatohepatitis. NAFLD pharmacotherapy asks for a search of new effective methods of treatment.
22-25 374
Abstract
Liver disease today is the number one digestive disease. According to WHO, there are more than 2 billion people with liver disease in the world, while in the CIS countries the registered number of people suffering from liver disease varies from 500 thousand to 1 million annually. Liver diseases with concomitant somatic, toxicological and surgical pathologies, along with viral hepatitis, are increasingly dominating the morbidity pattern.
26-28 386
Abstract
A majority of gastroenterologists all over the world today are focused on the study of functional motor disorders. The reason is quite simple: functional disorders anticipate many common gastrointestinal pathologies, being a response to stressful situations; when the basis pathology is already established, functional disorders determine the aggressiveness of the disease [1, 2].
BOWEL DISEASES
29-33 377
Abstract
The article presents a classification of functional bowel pathology; the reader's attention is drawn to the problem of functional constipation in irritable bowel syndrome, describes modern approaches to treatment of adult patients.
34-39 533
Abstract
Abdominal pain is one of the most common pain syndromes. In the United States, of 10 million people seeking medical care each year and complaining of acute abdominal pain, 40% are diagnosed with symptoms of acute abdomen. Every fourth patient is diagnosed with "functional" or "non-specific" abdominal pain. [1]
Gastroschool
40-45 440
Abstract
Nonalcoholic fatty liver disease (NAFLD), as well as alcoholic liver disease (ALD), pose a significant healthcare and social problem, since, despite apparently positive course of the diseases, they are accompanied by inflammatory changes in the liver resulting in cirrhosis and hepatic insufficiency.
Practice
46-48 377
Abstract
Chronic pancreatitis (CP) is one of the priority healthcare problems. Conservative therapy of CP today remains a challenge due to a variety of etiologies and pathogenetic mechanisms. Currently, there are no well-established algorithms for the treatment of CP; healthcare practitioner has to choose the most effective drug combinations for the treatment of the particular patient.
49-53 526
Abstract
The article is a literature review of the major etiopathogenetic mechanisms and recent approaches to the treatment of gastroesophageal reflux disease in patients with metabolic syndrome. Recent data on the role of insulin resistance, impaired neurohumoral regulation of the upper gastrointestinal tract in patients with gastroesophageal reflux disease and metabolic syndrome is presented.
DISSERTANT
54-65 443
Abstract
Dyspepsia syndrome associated with chronic gastritis is perhaps the most common problem faced by gastroenterologist. In order to develop a diagnostic and therapeutic strategy, it is necessary to determine the type of dyspepsia to relieve clinical symptoms, identify the presence of comorbidities that may impact the development and course of dyspepsia, and to reveal structural changes in the mucous membrane to detect chronic gastritis.
ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)
ISSN 2658-5790 (Online)
